
What if a medical device designed to save lives becomes a cybersecurity threat?
Imagine a hospital using connected infusion pumps, patient monitors, imaging systems, and remote healthcare devices.
These technologies help healthcare professionals monitor patients, deliver treatment, and make critical clinical decisions.
But what happens if a cyberattack disrupts a device, changes its configuration, or prevents clinicians from accessing essential information?
Suddenly, cybersecurity is no longer just an IT concern.
It becomes a patient safety concern.
As medical devices become increasingly connected, manufacturers must think beyond clinical performance and consider how cybersecurity vulnerabilities could affect device safety, availability, integrity, and reliability.
Under EU MDR and US FDA expectations, cybersecurity needs to be addressed throughout the medical device lifecycle.

Why Cybersecurity Matters in Medical Devices
Modern medical devices increasingly rely on software, wireless communication, cloud connectivity, mobile applications, and integration with hospital networks.
These capabilities can improve healthcare delivery, but they also introduce potential cybersecurity vulnerabilities.
A connected medical device may be exposed to unauthorized access, malware, insecure software components, communication failures, or exploitation of unpatched vulnerabilities.
For example, a cybersecurity incident could prevent access to patient monitoring information or interrupt communication between interconnected clinical systems.
The consequences depend on the device, its intended use, and the effectiveness of its safety controls.
Cybersecurity is not simply about protecting information. It is about protecting the medical functions patients depend on.
Can a Cyberattack Actually Affect Patient Safety?
Yes. Cybersecurity vulnerabilities can create pathways to patient harm, although the existence of a vulnerability does not necessarily mean an attack has occurred or that a patient has been injured.
Consider three hypothetical situations.
A Connected Infusion Pump
An infusion pump delivers medication according to prescribed settings.
If unauthorized access or malicious changes compromise its operation, this could create a medication delivery risk.
A Remote Patient Monitoring Device
A monitoring system transmits physiological measurements to healthcare professionals.
If an attack affects data integrity or availability, clinicians might receive incorrect information or experience delayed access to important patient data.
An AI-Enabled Diagnostic Device
An AI-enabled diagnostic system processes information to support clinical decisions.
If its software environment, inputs, or supporting systems are compromised, the reliability of its outputs may be affected.
These examples demonstrate why cybersecurity risk assessment should consider the potential clinical consequences of a security failure.
The Hidden Cybersecurity Risks Manufacturers Often Overlook
Medical device cybersecurity is more complex than installing antivirus software or protecting a network with a firewall.
Potential weaknesses include outdated software, insecure interfaces, weak authentication, hardcoded credentials, inadequate encryption, unsupported third-party components, and insufficient security testing.
Manufacturers should also consider risks introduced through maintenance access, remote updates, external service providers, and software supply chains.
One important challenge is that a device can meet its functional performance requirements while still having cybersecurity vulnerabilities.
A medical device that works correctly during normal testing is not automatically secure against cyber threats.
This is why security must be considered during design, verification, validation, deployment, and post-market monitoring.
What Does the FDA Expect From Medical Device Manufacturers?
The US FDA has strengthened its medical device cybersecurity framework.
Its February 2026 cybersecurity guidance addresses security considerations within the Quality Management System and recommends documentation for premarket submissions involving devices with cybersecurity risks.
Manufacturers should consider cybersecurity activities such as threat modelling, security risk management, secure architecture, cybersecurity testing, vulnerability management, and software component transparency.
For devices meeting the statutory definition of a cyber device, Section 524B of the Federal Food, Drug, and Cosmetic Act establishes specific premarket cybersecurity requirements.
These include plans for addressing post-market vulnerabilities, processes for cybersecurity maintenance and updates, and a Software Bill of Materials (SBOM).
Cybersecurity needs to be planned before market submission, not treated as an issue to resolve only after device deployment.
Cybersecurity Requirements Under EU MDR
Under EU MDR, manufacturers must address applicable safety and performance requirements, including software-related risks and protection against unauthorized access.
The MDCG 2019-16 Rev.1 cybersecurity guidance provides a framework for considering cybersecurity throughout the medical device lifecycle.
Manufacturers should evaluate how foreseeable security threats could affect safety, performance, and the intended medical function.
Cybersecurity assessments should be connected to software development, risk management, technical documentation, verification and validation, and post-market activities.
For connected medical devices, a cybersecurity vulnerability may also require evaluation of its potential clinical consequences.
What Is a Software Bill of Materials (SBOM)?
A Software Bill of Materials, commonly called an SBOM, is an inventory of software components used within a product.
It may identify commercial, open-source, and third-party software dependencies.
Why does this matter?
A vulnerability in one software component may affect multiple medical devices using that component.
Without visibility into software dependencies, manufacturers may struggle to identify affected products and respond to emerging vulnerabilities.
An SBOM supports component transparency and vulnerability management, but it is not a substitute for a complete cybersecurity risk assessment.
Why Cybersecurity Risk Management Must Be Continuous
Cybersecurity threats evolve.
A device that appears secure during initial development may face newly discovered vulnerabilities after market release.
Software updates, third-party dependency changes, new attack methods, and changes in the operating environment can affect its security profile.
This makes cybersecurity a lifecycle responsibility.
Manufacturers need processes to identify vulnerabilities, assess potential patient harm, prioritize remediation, manage patches, and communicate relevant information to healthcare providers and users.
Where necessary, cybersecurity findings should also feed into product risk management, corrective actions, and applicable regulatory reporting processes.
Cybersecurity does not end when a medical device receives regulatory authorization.
Five Cybersecurity Mistakes Medical Device Manufacturers Should Avoid
1. Treating Cybersecurity as an IT-Only Responsibility
Cybersecurity requires coordination between software development, engineering, quality assurance, regulatory affairs, clinical experts, and security professionals.
2. Performing Security Testing Too Late
Discovering major vulnerabilities shortly before submission can lead to redesign, additional testing, and documentation changes.
Security requirements should be considered from the early development stages.
3. Ignoring Third-Party Software Vulnerabilities
Even when manufacturers do not develop every software component themselves, they need to assess relevant vulnerabilities and risks associated with those components.
4. Failing to Plan for Security Updates
Manufacturers should establish controlled processes for evaluating, testing, deploying, and documenting cybersecurity updates.
5. Disconnecting Cybersecurity From Patient Risk
A technical vulnerability assessment is incomplete if it fails to consider how exploitation could affect clinical safety and device performance.
How Can Manufacturers Build More Secure Medical Devices?
An effective cybersecurity programme should begin during product development and continue throughout the device lifecycle.
Manufacturers should establish security requirements, identify threats, evaluate vulnerabilities, implement appropriate controls, and verify their effectiveness.
Security activities may include authentication and authorization controls, encryption, secure software update mechanisms, logging, vulnerability scanning, penetration testing, and documented incident response procedures.
Risk management should also consider the clinical impact of compromised device availability, integrity, or confidentiality.
The objective is not to claim that a device is impossible to hack.
It is to demonstrate that cybersecurity risks have been systematically identified, evaluated, controlled, and monitored.
Why Cybersecurity Is Becoming a Regulatory Priority
The growing use of connected medical devices, remote monitoring, AI-enabled diagnostics, and software-driven healthcare creates new opportunities alongside new security responsibilities.
Regulatory authorities increasingly expect manufacturers to demonstrate how cybersecurity has been considered within the product’s quality, safety, and lifecycle management processes.
For manufacturers targeting multiple markets, early cybersecurity planning can also help identify differences between applicable regulatory expectations.
A strong cybersecurity strategy supports patient safety, product reliability, evidence-based regulatory submissions, and long-term product management.
How Bioexcel Can Help
At Bioexcel, we support medical device and digital health manufacturers with clinical and regulatory documentation, risk management alignment, technical documentation review, and evidence-gap assessment.
Cybersecurity considerations should be evaluated alongside the device’s intended purpose, software functionality, clinical risks, verification and validation evidence, and applicable regulatory requirements.
For software-enabled and connected medical devices, Bioexcel can help manufacturers identify regulatory documentation needs, review the alignment between cybersecurity and clinical risk considerations, and coordinate an evidence strategy for regulatory submissions.
Specialist cybersecurity testing and technical security assessments should be performed by appropriately qualified cybersecurity professionals.
Medical device innovation is transforming healthcare.
But as devices become smarter and more connected, cybersecurity vulnerabilities can create risks that extend beyond data protection.
A medical device must not only perform its intended function.
It must also be designed and maintained with appropriate protection against cybersecurity threats that could affect patient safety.
Because in medical technology, cybersecurity is not just about protecting systems. It is about protecting patients.
Is Your Medical Device Prepared for Cybersecurity Review?
Before your next regulatory submission, assess whether cybersecurity risks, technical documentation, software validation, and patient safety considerations are properly connected.
Contact Bioexcel to discuss your medical device regulatory documentation and cybersecurity evidence-readiness needs.
Need Help With Something Like This?
Talk to our team about the clinical, regulatory or scientific evidence your program needs.
Discuss Your Requirement